Table 5.
Type | No (%) | Mean Age |
M:F | Symptomatic | EHBD disease | Stones | Node + |
---|---|---|---|---|---|---|---|
EMZL | 16 (24%) | 68.8 | 4:12 | 14/15, 93% | 2/16#, 12.5% | 7/13, 54% | 2/11, 18% |
DLBCL* | 16 (24%) | 60.4 | 8:8 | 12/15, 80% | 6/16, 37.5% | 8/12, 66% | 4/12, 33% |
FL | 10 (15%) | 56.5 | 4:6 | 8/9, 89% | 4/10, 40% | 3/7, 43% | 2/10, 20% |
LBL | 4 (6%) | 35.3 | 2:2 | 4/4, 100% | 0/4, 0% | 0/4, 0% | 0/3, 0% |
One case involved both gallbladder and common bile duct
Includes one case of T-cell histiocyte rich large B-cell lymphoma
DLBCL – diffuse large B-cell lymphoma; EHBD – extrahepatic bile duct; EMZL – extranodal marginal zone lymphoma; FL – follicular lymphoma; LBL – lymphoblastic lymphoma